Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 531

1.

Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial.

Bochner BH, Dalbagni G, Sjoberg DD, Silberstein J, Keren Paz GE, Donat SM, Coleman JA, Mathew S, Vickers A, Schnorr GC, Feuerstein MA, Rapkin B, Parra RO, Herr HW, Laudone VP.

Eur Urol. 2014 Dec 8. pii: S0302-2838(14)01235-4. doi: 10.1016/j.eururo.2014.11.043. [Epub ahead of print]

PMID:
25496767
[PubMed - as supplied by publisher]
2.

A systematic literature review of life expectancy prediction tools for localized prostate cancer patients.

Kent M, Vickers AJ.

J Urol. 2014 Nov 15. pii: S0022-5347(14)04929-5. doi: 10.1016/j.juro.2014.11.082. [Epub ahead of print]

PMID:
25463998
[PubMed - as supplied by publisher]
3.

WITHDRAWN: Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting.

Ezzo J, Richardson MA, Vickers A, Allen C, Dibble S, Issell BF, Lao L, Pearl M, Ramirez G, Roscoe JA, Shen J, Shivnan JC, Streitberger K, Treish I, Zhang G, Manheimer E.

Cochrane Database Syst Rev. 2014 Nov 21;11:CD002285. doi: 10.1002/14651858.CD002285.pub3. No abstract available.

PMID:
25412832
[PubMed - in process]
4.

Response from the author.

Vickers AJ.

Clin Trials. 2014 Dec;11(6):628. doi: 10.1177/1740774514553486. No abstract available.

PMID:
25389228
[PubMed - in process]
5.

Markers for the early detection of prostate cancer: some principles for statistical reporting and interpretation.

Vickers AJ.

J Clin Oncol. 2014 Dec 20;32(36):4033-4. doi: 10.1200/JCO.2014.58.5547. Epub 2014 Nov 3. No abstract available.

PMID:
25366689
[PubMed - in process]
6.

Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.

Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco Jr FJ, Rabah DM, Klein EA, Ciezki JP, Gao T, Kattan MW, Stephenson AJ.

Eur Urol. 2014 Oct 6. pii: S0302-2838(14)00956-7. doi: 10.1016/j.eururo.2014.09.019. [Epub ahead of print]

PMID:
25301759
[PubMed - as supplied by publisher]
7.

Clinical trials in crisis: Four simple methodologic fixes.

Vickers AJ.

Clin Trials. 2014 Dec;11(6):615-21. doi: 10.1177/1740774514553681. Epub 2014 Oct 1.

PMID:
25278228
[PubMed - in process]
8.

Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer.

Martin NE, Massey L, Stowell C, Bangma C, Briganti A, Bill-Axelson A, Blute M, Catto J, Chen RC, D'Amico AV, Feick G, Fitzpatrick JM, Frank SJ, Froehner M, Frydenberg M, Glaser A, Graefen M, Hamstra D, Kibel A, Mendenhall N, Moretti K, Ramon J, Roos I, Sandler H, Sullivan FJ, Swanson D, Tewari A, Vickers A, Wiegel T, Huland H.

Eur Urol. 2014 Sep 15. pii: S0302-2838(14)00845-8. doi: 10.1016/j.eururo.2014.08.075. [Epub ahead of print]

PMID:
25234359
[PubMed - as supplied by publisher]
Free Article
9.

A simple schema for informed decision making about prostate cancer screening.

Vickers AJ, Edwards K, Cooperberg MR, Mushlin AI.

Ann Intern Med. 2014 Sep 16;161(6):441-2. doi: 10.7326/M14-0151. No abstract available.

PMID:
25222389
[PubMed - indexed for MEDLINE]
10.

Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines.

Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP 3rd, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shanefelt TM, Vickers AJ, Wake R, Shead DA, Ho M.

J Natl Compr Canc Netw. 2014 Sep;12(9):1211-9; quiz 1219.

PMID:
25190691
[PubMed - in process]
11.

European Urology: Serving Our Readership Through Systematic Peer Review, Use of Reporting Standards, and Encouragement of Postpublication Review.

Catto JW, Cooperberg MR, Cornu JN, Gratzke C, Novara G, Shariat SF, Vickers A.

Eur Urol. 2014 Aug 27. pii: S0302-2838(14)00770-2. doi: 10.1016/j.eururo.2014.08.017. [Epub ahead of print] No abstract available.

PMID:
25175422
[PubMed - as supplied by publisher]
12.

The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men.

Vedder MM, de Bekker-Grob EW, Lilja HG, Vickers AJ, van Leenders GJ, Steyerberg EW, Roobol MJ.

Eur Urol. 2014 Dec;66(6):1109-15. doi: 10.1016/j.eururo.2014.08.011. Epub 2014 Aug 26.

PMID:
25168616
[PubMed - in process]
13.

Extended Pelvic Lymph Node Dissection in Prostate Cancer Patients Previously Treated With Surgery for Lower Urinary Tract Symptoms.

Fossati N, Sjoberg DD, Capitanio U, Gandaglia G, Larcher A, Nini A, Mirone V, Vickers AJ, Montorsi F, Briganti A.

BJU Int. 2014 Aug 28. doi: 10.1111/bju.12912. [Epub ahead of print]

PMID:
25168453
[PubMed - as supplied by publisher]
14.

Calibration of Risk Prediction Models: Impact on Decision-Analytic Performance.

Van Calster B, Vickers AJ.

Med Decis Making. 2014 Aug 25. pii: 0272989X14547233. [Epub ahead of print]

PMID:
25155798
[PubMed - as supplied by publisher]
15.

Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.

Nordström T, Vickers A, Assel M, Lilja H, Grönberg H, Eklund M.

Eur Urol. 2014 Aug 20. pii: S0302-2838(14)00752-0. doi: 10.1016/j.eururo.2014.08.010. [Epub ahead of print]

PMID:
25151013
[PubMed - as supplied by publisher]
16.

Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.

Nazarian A, Lawlor K, Yi SS, Philip J, Ghosh M, Yaneva M, Villanueva J, Saghatelian A, Assel M, Vickers AJ, Eastham JA, Scher HI, Carver BS, Lilja H, Tempst P.

Mol Cell Proteomics. 2014 Nov;13(11):3082-96. doi: 10.1074/mcp.M114.038836. Epub 2014 Jul 23.

PMID:
25056937
[PubMed - in process]
17.

Guidelines for Reporting of Statistics in European Urology.

Vickers AJ, Sjoberg DD.

Eur Urol. 2014 Jul 15. pii: S0302-2838(14)00598-3. doi: 10.1016/j.eururo.2014.06.024. [Epub ahead of print]

PMID:
25037638
[PubMed - as supplied by publisher]
18.

Copy number alteration burden predicts prostate cancer relapse.

Hieronymus H, Schultz N, Gopalan A, Carver BS, Chang MT, Xiao Y, Heguy A, Huberman K, Bernstein M, Assel M, Murali R, Vickers A, Scardino PT, Sander C, Reuter V, Taylor BS, Sawyers CL.

Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):11139-44. doi: 10.1073/pnas.1411446111. Epub 2014 Jul 14.

PMID:
25024180
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Molecular epidemiology of nasal isolates of methicillin-resistant Staphylococcus aureus from Jordan.

Aqel AA, Alzoubi HM, Vickers A, Pichon B, Kearns AM.

J Infect Public Health. 2014 Jul 4. pii: S1876-0341(14)00080-X. doi: 10.1016/j.jiph.2014.05.007. [Epub ahead of print]

PMID:
25002017
[PubMed - as supplied by publisher]
20.

Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.

Ankerst DP, Hoefler J, Bock S, Goodman PJ, Vickers A, Hernandez J, Sokoll LJ, Sanda MG, Wei JT, Leach RJ, Thompson IM.

Urology. 2014 Jun;83(6):1362-7. doi: 10.1016/j.urology.2014.02.035.

PMID:
24862395
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk